Skip to content
Dohányzásról való leszokás

Dohányzásról való leszokás kezelések

Bongéssze az elérheeto dohányzásról való leszokás kezeléseket. Mindegyik tartalmazza a fuggetlen EU-s orvos felulvizsgalatát, eredeti gyogyszereket engedélyes gyogyszertarakbol és diszkret expressz kézbesitést.

2026-04-12 Kezelések

Interested in Dohányzásról való leszokás?

Complete a confidential health assessment reviewed by an independent EU-registered doctor.

Start Assessment

Smoking cessation kezelések Európában

Tobacco smoking remains the leading preventable cause of death and disease in the European Union. According to WHO data, tobacco kills approximately 700,000 people in the EU each year. The health consequences of smoking are well-established: it is causally linked to lung cancer, chronic obstructive pulmonary disease (COPD), cardiovascular disease, stroke, and numerous other serious conditions. Despite widespread awareness of these risks, nicotine dependence is a recognised chronic relapsing disorder that makes cessation profoundly difficult without appropriate support.

Nicotine acts on reward pathways in the brain, producing dependence through both physical and psychological mechanisms. When a smoker attempts to quit, withdrawal symptoms — including cravings, irritability, anxiety, difficulty concentrating, and disturbed sleep — can be severe and are a primary driver of relapse. This is why the World Health Organization classifies tobacco dependence as a medical condition warranting treatment.

Clinical evidence consistently demonstrates that the combination of pharmacological support and behavioural counselling produces the highest cessation rates. The EMA has approved two prescription medications specifically for smoking cessation: varenicline (sold under the brand name Champix) and bupropion (originally an antidepressant, repurposed for smoking cessation). Nicotine replacement therapy (NRT) — available in patch, gum, lozenge, inhaler, and nasal spray formulations — provides another effective option for reducing withdrawal symptoms.

Access to evidence-based smoking cessation support through a qualified medical professional can significantly improve the chances of a successful and sustained quit attempt.

Elérhető kezelések

The following medications may be available for smoking cessation through EU-registered doctors. This comparison is provided for informational purposes only.

MedicationActive IngredientClassTypical Course Duration
Varenicline (Champix)VareniclineNicotinic receptor partial agonist12 weeks (extendable to 24)
BupropionBupropion HClAtypical antidepressant (NDRI)7–9 weeks
Nicotine replacement therapyNicotineNRT (patch, gum, lozenge, inhaler)8–12 weeks

Key distinctions:

  • Varenicline (Champix): Considered the most effective single pharmacotherapy for smoking cessation in clinical trials, with quit rates approximately three times higher than placebo at 12 months. Taken as a standard tablet twice daily after an initial titration period. Not suitable for adolescents under 18.
  • Bupropion: An atypical antidepressant with dopamine and noradrenaline reuptake inhibition activity. Supports cessation by reducing cravings and withdrawal. Important contraindications include seizure history and eating disorders.
  • Nicotine replacement therapy: Reduces withdrawal symptoms by providing nicotine without tobacco combustion products. Over-the-counter formulations are available without prescription; higher-dose or combination NRT may be discussed with a doctor.

Hogyan szerezhető be a kezelések online

A Prescrivia technológiai közvetítőként működik: nem írunk fel gyógyszereket, nem alkalmazunk orvosokat és nem értékesítünk gyógyszereket. Platformunk pácienseket kapcsol össze független, EU-ban regisztrált orvosokkal, akik bizalmas online egészségügyi felméréseket végezhetnek.

A folyamat a következő:

  1. Töltse ki az egészségügyi kérdőívet — Answer a structured set of medical questions covering your smoking history, nicotine dependence level, previous quit attempts, current medications, mental health history, and relevant medical conditions.

  2. Independent doctor review — An independent EU-registered doctor reviews your assessment. If a prescription smoking cessation medication is clinically appropriate, the doctor may issue a prescription. If contraindications are identified, the doctor will advise on alternative options.

  3. Recept és teljesítés — If a prescription is issued, it is passed to a licensed EU pharmacy partner. The medication is dispensed and delivered to your address.

Fontos: A Prescrivia nem garantálja a recept kiállítását. Minden felírási döntést független, képzett orvosok hoznak az Ön egyéni klinikai körülményei alapján.

Összehasonlításunk

A Prescrivia-n keresztülSzemélyes orvosi konzultáció
Elérhetőség24/7 online assessmentSubject to appointment availability
Várakozási időAssessment reviewed within hoursDays to weeks depending on location
Utazás szükségesNoYes
Felírási döntésMade by independent EU-registered doctorMade by your GP
Ongoing monitoringSupported via follow-up assessmentsManaged by your GP
KöltségTransparent pricing displayed upfrontVaries by country and healthcare system

Note: Smokers with complex psychiatric histories, those taking multiple medications with significant interaction profiles, or pregnant women should seek in-person consultation for smoking cessation support. Prescrivia’s platform complements but does not replace comprehensive quit programmes that include behavioural support.

Források

Az oldalon található orvosi információk az alábbi forrásokon alapulnak:

  • European Medicines Agency (EMA). Champix (varenicline) — Summary of Product Characteristics. Available at: ema.europa.eu
  • World Health Organization (WHO). Tobacco — Key facts. who.int
  • Cahill K, et al. Pharmacological interventions for smoking cessation: an overview and network meta-analysis. Cochrane Database Syst Rev. 2013.

Ez a tartalom rendszeresen felülvizsgálatra kerül a frissített klinikai irányelvek tükrözése érdekében. Kizárólag tájékoztató jelleggel készült, és nem minősül orvosi tanácsadásnak. Mindig konzultáljon képzett egészségügyi szakemberrel az Ön egyéni egészségügyi körülményeire vonatkozó tanácsért.

Frequently asked questions

Megkaphatom a Dohányzásról való leszokás készítményt online Európában?
A készítményhez online közvetítő platformokon keresztül férhet hozzá, amelyek független, EU-ban regisztrált orvosokkal kötik össze Önt. A bizalmas egészségügyi kérdőív kitöltése után az orvos felméri, hogy a gyógyszer klinikailag megfelelő-e az Ön számára.
Hogyan hat a Dohányzásról való leszokás?
Varenicline is a partial agonist of nicotinic acetylcholine receptors. It reduces cravings by partially stimulating nicotine receptors in the brain, and reduces the rewarding effects of smoking by blocking nicotine from fully binding to those receptors. Clinical trials demonstrate significantly higher quit rates compared to placebo and comparable or superior efficacy to bupropion.
Biztonságos-e for everyone?
Bupropion is contraindicated in patients with a history of seizures, eating disorders, bipolar disorder, or those taking monoamine oxidase inhibitors (MAOIs). It also has interactions with various other medications. A thorough medical assessment is essential before it is prescribed. The reviewing doctor will evaluate your full health profile.
Do I need prescription medication to stop smoking?
Not necessarily. Many people successfully quit using over-the-counter nicotine replacement therapy (NRT) — patches, gum, lozenges, and inhalers — without prescription medication. However, prescription medications such as varenicline and bupropion have demonstrated higher cessation rates in clinical trials and may be appropriate for those who have not succeeded with NRT alone or who have a high level of nicotine dependence.
Mennyi ideig does a course of smoking cessation medication typically last?
The standard treatment duration for varenicline is 12 weeks, with an optional additional 12-week course to further consolidate abstinence. Bupropion treatment is typically 7–9 weeks. Nicotine replacement therapy is generally used for 8–12 weeks, though duration may be extended based on individual need.
A Prescrivia közvetítő platform. Nem nyújtunk orvosi szolgáltatásokat, nem írunk fel kezeléseket és nem adunk ki gyógyszereket. Minden orvosi döntést független, EU-ban regisztrált orvosok hoznak. Minden gyógyszert engedéllyel rendelkező EU-gyógyszertárak adnak ki. Ez a platform összeköti a betegeket és az egészségügyi szolgáltatókat.

Written by Prescrivia Editorial. Medical information sourced from European Medicines Agency (EMA), World Health Organization (WHO), and published clinical data.

This content is informational only and does not constitute medical advice.

Last updated:

Készen áll a kezdésre?

Töltse ki a bizalmas egészségügyi felmérést körülbelül 3 perc alatt.